Committed to sharing our science

Committed to sharing our science

scientist testing potential medicines

315 results available

Differences in Healthcare Resource Use and Cost by Pharmacotherapy Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Real-World Analysis of Claims Data

American Journal of Cardiovascular Drugs

Butzner M, et al

August 22, 2024
Pharmacokinetics, Disposition, and Biotransformation of the Cardiac Myosin Inhibitor Aficamten in Humans

Pharmacology Research & Perspectives

Xu, D et al

September 10, 2024
Menopausal Status and Clinical Outcomes in Women with Heart Failure with Reduced Ejection Fraction: the GALACTIC-HF Trial

Poster, ESC 2024

Pabon, MA et al

September 2, 2024
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM

Journal of the American College of Cardiology

Maron, MS et al

September 30, 2024
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM

Oral Presentation, HFSA 2024

Maron, MS et al

September 30, 2024